1. Home
  2. GRI vs IMTE Comparison

GRI vs IMTE Comparison

Compare GRI & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GRI Bio Inc.

GRI

GRI Bio Inc.

HOLD

Current Price

$2.49

Market Cap

1.9M

Sector

Health Care

ML Signal

HOLD

Logo Integrated Media Technology Limited

IMTE

Integrated Media Technology Limited

HOLD

Current Price

$0.58

Market Cap

2.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRI
IMTE
Founded
2018
2008
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Appliances
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.9M
2.0M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
GRI
IMTE
Price
$2.49
$0.58
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$644.00
N/A
AVG Volume (30 Days)
338.7K
74.8K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.50
52 Week High
$11.12
$3.17

Technical Indicators

Market Signals
Indicator
GRI
IMTE
Relative Strength Index (RSI) 53.72 40.11
Support Level $1.21 $0.50
Resistance Level $2.87 $1.10
Average True Range (ATR) 0.23 0.09
MACD -0.09 -0.01
Stochastic Oscillator 52.73 9.14

Price Performance

Historical Comparison
GRI
IMTE

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

About IMTE Integrated Media Technology Limited

Integrated Media Technology Ltd is mainly engaged in the business of manufacture and sale of nano-coated plates for filters, the manufacture and sale of electronic glass, Halal certification and distribution of Halal products, and new energy products and services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.

Share on Social Networks: